Opening New Frontiers By Advancing The Promise of PI Signaling Pathways

Scott W. Lowe, Ph.D.

Select a team to find out more

Scott W. Lowe, Ph.D.

Scott W. Lowe, Ph.D.

Investigator, Howard Hughes Medical Institute, Chair, Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center

Dr. Scott Lowe is Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and an investigator for the Howard Hughes Medical Institute.

Scott received a B.S. from the University of Wisconsin-Madison and earned a Ph.D. from the Massachusetts Institute of Technology. He initiated independent research at Cold Spring Harbor Laboratory, where his group make important contributions to our understanding of the p53 tumor suppressor network, as well as the processes of multi-step carcinogenesis, cellular senescence, and tumor-cell drug resistance.  At MSKCC, Scott’s work applying mouse models, functional genomics and cancer genomics in a coordinated effort to identify cancer drivers and dependencies revealed fundamental insights into cancer mechanisms and identified potential therapeutic targets.

Scott has received several awards, including a Sidney Kimmel Scholar Award, a Rita Allen Scholar Award, the Outstanding Investigator Award from the American Association for Cancer Research, the Paul Marks Prize, and the Alfred G. Knudsen Award.  He has also been elected to the American Academy of Arts and Sciences and the National Academy of Sciences.